Medtronic Price to Sales Ratio 2010-2024 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of September 19, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-20 | 89.34 | 3.63 | |
| 2024-07-31 | 80.32 | $24.63 | 3.26 |
| 2024-04-30 | 79.53 | $24.30 | 3.27 |
| 2024-01-31 | 86.06 | $24.25 | 3.55 |
| 2023-10-31 | 68.79 | $23.98 | 2.87 |
| 2023-07-31 | 84.83 | $23.68 | 3.58 |
| 2023-04-30 | 87.22 | $23.43 | 3.72 |
| 2023-01-31 | 79.56 | $23.00 | 3.46 |
| 2022-10-31 | 82.30 | $22.95 | 3.59 |
| 2022-07-31 | 86.48 | $23.05 | 3.75 |
| 2022-04-30 | 96.80 | $23.41 | 4.13 |
| 2022-01-31 | 95.43 | $23.47 | 4.07 |
| 2021-10-31 | 109.85 | $23.46 | 4.68 |
| 2021-07-31 | 119.76 | $23.33 | 5.13 |
| 2021-04-30 | 118.81 | $22.26 | 5.34 |
| 2021-01-31 | 100.53 | $20.65 | 4.87 |
| 2020-10-31 | 90.36 | $20.62 | 4.38 |
| 2020-07-31 | 86.19 | $20.67 | 4.17 |
| 2020-04-30 | 86.65 | $21.39 | 4.05 |
| 2020-01-31 | 101.86 | $22.96 | 4.44 |
| 2019-10-31 | 95.63 | $22.82 | 4.19 |
| 2019-07-31 | 89.07 | $22.62 | 3.94 |
| 2019-04-30 | 77.17 | $22.48 | 3.43 |
| 2019-01-31 | 76.39 | $22.44 | 3.40 |
| 2018-10-31 | 77.20 | $22.30 | 3.46 |
| 2018-07-31 | 77.15 | $21.96 | 3.51 |
| 2018-04-30 | 68.12 | $21.93 | 3.11 |
| 2018-01-31 | 73.02 | $21.67 | 3.37 |
| 2017-10-31 | 68.45 | $21.49 | 3.19 |
| 2017-07-31 | 70.97 | $21.60 | 3.29 |
| 2017-04-30 | 69.86 | $21.32 | 3.28 |
| 2017-01-31 | 63.58 | $20.94 | 3.04 |
| 2016-10-31 | 68.19 | $20.55 | 3.32 |
| 2016-07-31 | 72.49 | $20.21 | 3.59 |
| 2016-04-30 | 65.16 | $20.19 | 3.23 |
| 2016-01-31 | 62.18 | $21.47 | 2.90 |
| 2015-10-31 | 60.25 | $20.93 | 2.88 |
| 2015-07-31 | 63.54 | $20.38 | 3.12 |
| 2015-04-30 | 60.05 | $19.57 | 3.07 |
| 2015-01-31 | 57.36 | $17.49 | 3.28 |
| 2014-10-31 | 54.53 | $17.27 | 3.16 |
| 2014-07-31 | 49.15 | $17.03 | 2.89 |
| 2014-04-30 | 46.61 | $16.78 | 2.78 |
| 2014-01-31 | 44.61 | $16.62 | 2.68 |
| 2013-10-31 | 45.06 | $16.44 | 2.74 |
| 2013-07-31 | 43.13 | $16.27 | 2.65 |
| 2013-04-30 | 36.25 | $16.13 | 2.25 |
| 2013-01-31 | 35.99 | $15.85 | 2.27 |
| 2012-10-31 | 31.92 | $15.60 | 2.05 |
| 2012-07-31 | 30.08 | $15.40 | 1.95 |
| 2012-04-30 | 28.96 | $15.22 | 1.90 |
| 2012-01-31 | 29.06 | $14.84 | 1.96 |
| 2011-10-31 | 26.01 | $14.73 | 1.77 |
| 2011-07-31 | 26.79 | $14.54 | 1.84 |
| 2011-04-30 | 30.83 | $14.32 | 2.15 |
| 2011-01-31 | 28.13 | $14.04 | 2.00 |
| 2010-10-31 | 25.71 | $13.94 | 1.84 |
| 2010-07-31 | 26.80 | $13.79 | 1.94 |
| 2010-04-30 | 31.48 | $13.86 | 2.27 |
| 2010-01-31 | 30.76 | $13.86 | 2.22 |
| 2009-10-31 | 25.49 | $13.50 | 1.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $114.744B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |